Diagnosis and management of pneumonia in the intensive care unit

Victor J. Cardenas

Research output: Contribution to journalArticle

Abstract

Ventilator-associated pneumonia is a significant contributor to excess morbidity and mortality in the ICU. Alteration of physical defenses, bacterial flora, and immune response contribute to the susceptibility of the critically ill ventilated patient. Controversies regarding its definition continue to complicate the understanding of the extent of the disease and evaluation of the outcome of therapies. Traditional parameters, such as clinical suspicion with standard tracheal aspirates, are associated with overuse of antibiotics, a prime risk factor for development of resistant organisms and increased mortality. Global emergence of resistance is also a major concern. Whether invasive methods have any substantial clinical benefit either through improved patient outcomes or lower rates of resistance remains to be proved. In patients who fail to respond to therapy, a search for nonpulmonary infections and noninfectious causes of pulmonary infiltrates is essential. Finally, preventative measures offer additional areas of investigation that could favorably impact on the incidence of infection.

Original languageEnglish (US)
Pages (from-to)379-395
Number of pages17
JournalChest Surgery Clinics of North America
Volume12
Issue number2
DOIs
StatePublished - 2002

Fingerprint

Intensive Care Units
Pneumonia
Ventilator-Associated Pneumonia
Mortality
Infection
Critical Illness
Anti-Bacterial Agents
Morbidity
Lung
Incidence
Therapeutics

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Diagnosis and management of pneumonia in the intensive care unit. / Cardenas, Victor J.

In: Chest Surgery Clinics of North America, Vol. 12, No. 2, 2002, p. 379-395.

Research output: Contribution to journalArticle

@article{fcf46ed0abcd4b2992aa4fb19b93666a,
title = "Diagnosis and management of pneumonia in the intensive care unit",
abstract = "Ventilator-associated pneumonia is a significant contributor to excess morbidity and mortality in the ICU. Alteration of physical defenses, bacterial flora, and immune response contribute to the susceptibility of the critically ill ventilated patient. Controversies regarding its definition continue to complicate the understanding of the extent of the disease and evaluation of the outcome of therapies. Traditional parameters, such as clinical suspicion with standard tracheal aspirates, are associated with overuse of antibiotics, a prime risk factor for development of resistant organisms and increased mortality. Global emergence of resistance is also a major concern. Whether invasive methods have any substantial clinical benefit either through improved patient outcomes or lower rates of resistance remains to be proved. In patients who fail to respond to therapy, a search for nonpulmonary infections and noninfectious causes of pulmonary infiltrates is essential. Finally, preventative measures offer additional areas of investigation that could favorably impact on the incidence of infection.",
author = "Cardenas, {Victor J.}",
year = "2002",
doi = "10.1016/S1052-3359(02)00008-X",
language = "English (US)",
volume = "12",
pages = "379--395",
journal = "Thoracic Surgery Clinics",
issn = "1547-4127",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Diagnosis and management of pneumonia in the intensive care unit

AU - Cardenas, Victor J.

PY - 2002

Y1 - 2002

N2 - Ventilator-associated pneumonia is a significant contributor to excess morbidity and mortality in the ICU. Alteration of physical defenses, bacterial flora, and immune response contribute to the susceptibility of the critically ill ventilated patient. Controversies regarding its definition continue to complicate the understanding of the extent of the disease and evaluation of the outcome of therapies. Traditional parameters, such as clinical suspicion with standard tracheal aspirates, are associated with overuse of antibiotics, a prime risk factor for development of resistant organisms and increased mortality. Global emergence of resistance is also a major concern. Whether invasive methods have any substantial clinical benefit either through improved patient outcomes or lower rates of resistance remains to be proved. In patients who fail to respond to therapy, a search for nonpulmonary infections and noninfectious causes of pulmonary infiltrates is essential. Finally, preventative measures offer additional areas of investigation that could favorably impact on the incidence of infection.

AB - Ventilator-associated pneumonia is a significant contributor to excess morbidity and mortality in the ICU. Alteration of physical defenses, bacterial flora, and immune response contribute to the susceptibility of the critically ill ventilated patient. Controversies regarding its definition continue to complicate the understanding of the extent of the disease and evaluation of the outcome of therapies. Traditional parameters, such as clinical suspicion with standard tracheal aspirates, are associated with overuse of antibiotics, a prime risk factor for development of resistant organisms and increased mortality. Global emergence of resistance is also a major concern. Whether invasive methods have any substantial clinical benefit either through improved patient outcomes or lower rates of resistance remains to be proved. In patients who fail to respond to therapy, a search for nonpulmonary infections and noninfectious causes of pulmonary infiltrates is essential. Finally, preventative measures offer additional areas of investigation that could favorably impact on the incidence of infection.

UR - http://www.scopus.com/inward/record.url?scp=0035992097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035992097&partnerID=8YFLogxK

U2 - 10.1016/S1052-3359(02)00008-X

DO - 10.1016/S1052-3359(02)00008-X

M3 - Article

C2 - 12122830

AN - SCOPUS:0035992097

VL - 12

SP - 379

EP - 395

JO - Thoracic Surgery Clinics

JF - Thoracic Surgery Clinics

SN - 1547-4127

IS - 2

ER -